Nuclear Imaging Equipment Market Size to Reach USD 3.5 Billion in 2028, Says Reports and Data

Increasing focus on personalized medicines and technological advancements in radiotracers will drive market growth.

Increasing focus on personalized medicines and technological advancements in radiotracers will drive market growth.

The global nuclear imaging equipment market size is expected to reach USD 3.5 billion in 2028, registering a CAGR of 4.6% over the forecast period, according to the latest report by Reports and Data. Major factors driving market revenue growth are increasing focus on personalized medicines and technological advancements in radiotracers. Moreover, growing pharmaceutical industries and rising prevalence of chronic diseases such as cancer will enhance market growth. For instance, according to a report by World Health Organization (WHO), rising chronic diseases accounted for around three-quarters of all deaths in 2020 globally.

Nuclear imaging equipment and devices play significant role in the diagnosis of radioactive substances (also known as radiopharmaceuticals or radiotracers) in patients. These radiotracers are used in therapeutics and diagnosis treatment of cardiac cancer and other neurological disorders.

Rising diagnostic applications on cardiovascular diseases, shift from standalone to hybrid modalities, and development of nuclear imaging equipment due to technological advancements are expected to accelerate market growth over the forecast period. In addition, government funding for R&D activities to develop new technologies in healthcare sector will further drive market growth. In addition, growing awareness about significance of early diagnosis and developments of new radiopharmaceuticals will create growth opportunities for the market.

Moreover, the market growth is projected to register an upward trend owing to increasing demand for data integrated imaging systems. Hospitals and clinicians across the world are now using data integrated imaging systems for generation of 3D images and get detailed information on the diagnostic history of concerned patient.

Access Free sample PDF Copy of the Report @

Advancement of nuclear imaging technology enables effective patient management for monitoring tumor and helps in achieving standardization and precision in imaging techniques for clinical trials. For instance, in September, 2018, Bruker introduced a preclinical PET/CT Si78 scanner at the World Molecular Imaging Congress in Seattle, the U.S., for whole-body molecular imaging. The single scanner combines Micro-Computed Tomography (CT) and Positron Emission Tomography (PET) technologies and imaging software platform ParaVision 360.

However, expensive nuclear imaging equipment, complex installation and equipment procedures and lack of trained professionals to operate such technology are major factors that will restrain the nuclear imaging equipment market growth to a certain extent over the forecast period.

Shorter half-life of radiopharmaceutical, high maintenance cost, and shortage of radionuclide Tc99m (technetium 99) also create challenges for the market growth. Tc99m is generally used in nuclear medicine scans for imaging the patient’s body.

Buy now your Exclusive copy of Report @

Some Key Highlight in the Report:

  • The Single Photon-Emission Computed Tomography (SPECT) imaging systems accounted for largest revenue share in the global market in 2020 due to its lower cost compared to hybrid PET (Positron Emission Tomography) imaging systems.
  • The oncology segment is projected to register a significant CAGR during the forecast period due to rising prevalence of tumors.
  • The hospitals segment accounted for largest revenue share among the end user segments in the global market in 2020 due to large scale adoption of advanced nuclear imaging systems.
  • North America is expected to account for largest revenue share of the market over the forecast period due to rising adoption of nuclear imaging technologies and introduction of new radiopharmaceuticals for diagnosis.
  • Revenue from the Asia Pacific nuclear imaging equipment market is projected to grow at a high rate.
  • Prominent players in the market are Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, Toshiba Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., Mediso Medical Imaging Systems Co., Ltd., CMR Naviscan Corporation, Digirad Corporation, SurgiEye GmbH, and Positron Corporation.

Request for Custom Research @

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global nuclear imaging equipment market on the basis of type, application, end user and region:

Type Outlook (Revenue, USD Billion; 2018 – 2028)

  • SPECT Imaging Systems
  • PET Imaging Systems
  • Planar Scintigraphy Imaging Systems

Application Outlook (Revenue, USD Billion; 2018 – 2028)

  • Neurology
  • Oncology
  • Cardiology
  • Others

End User Outlook (Revenue, USD Billion; 2018 – 2028)

  • Hospitals
  • Imaging Centers
  • Academic & Research Centers
  • Others

Regional Outlook (Revenue, USD Billion; 2018 – 2028)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

Explore Reports and Data’s Prime Analysis of the global Pharmaceutical & Healthcare Industry:

Computer Aided Detection (CAD) Market Size, Share & Trends Analysis Report by Application (Oncology {Breast Cancer, Lung Cancer, Colon, Prostate Cancer, Liver Cancer, Bone Cancer}, Cardiovascular, Musculoskeletal, Neurological), by Breast CAD Imaging Modalities (Mammography, MRI, Ultrasound Imaging, Tomosynthesis, Nuclear Imaging, Others) by Imaging Modalities (X-Ray Imaging, Computed Tomography, Ultrasound Imaging, MRI, Nuclear Medicine Imaging) And Region Forecasts To 2028

Medical Digital Imaging Systems Market Size, Share & Analysis, By Product Type (Computed Tomography (CT), Ultrasound, X-ray, Nuclear Imaging, Magnetic Resonance Imaging (MRI), Others), By Application (Cardiology, Neurology, Orthopedics, Oncology, Gastroenterology, Gynecology, Others), By End-Use (Hospitals And Clinics, Diagnostic Centers, Others), And Region, Segment Forecasts To 2027

Teleradiology Market Size, Share & Analysis By Imaging Technique (Computed Tomography (CT), X-ray, Nuclear Imaging, Fluoroscopy, Mammography, Others), By End-Use (Hospitals, Diagnostic Centers, Ambulatory Service Centers, Others), Region- Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Read Full Press Release: